<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yan G</submitter><funding>NHLBI NIH HHS</funding><pagination>482-501</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10940206</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>134(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Mitochondrial dysfunction is a primary driver of cardiac contractile failure; yet, the cross talk between mitochondrial energetics and signaling regulation remains obscure. Ponatinib, a tyrosine kinase inhibitor used to treat chronic myeloid leukemia, is among the most cardiotoxic tyrosine kinase inhibitors and causes mitochondrial dysfunction. Whether ponatinib-induced mitochondrial dysfunction triggers the integrated stress response (ISR) to induce ponatinib-induced cardiotoxicity remains to be determined.&lt;h4>Methods&lt;/h4>Using human induced pluripotent stem cells-derived cardiomyocytes and a recently developed mouse model of ponatinib-induced cardiotoxicity, we performed proteomic analysis, molecular and biochemical assays to investigate the relationship between ponati</pubmed_abstract><journal>Circulation research</journal><pubmed_title>Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity.</pubmed_title><pmcid>PMC10940206</pmcid><funding_grant_id>R00 HL130416</funding_grant_id><funding_grant_id>R01 HL164729</funding_grant_id><funding_grant_id>R01 HL149891</funding_grant_id><funding_grant_id>R01 HL148756</funding_grant_id><funding_grant_id>K99 HL130416</funding_grant_id><funding_grant_id>R01 HL162584</funding_grant_id><funding_grant_id>T32 HL007829</funding_grant_id><funding_grant_id>R01 HL133080</funding_grant_id><pubmed_authors>Ong SG</pubmed_authors><pubmed_authors>Pinho S</pubmed_authors><pubmed_authors>Kwon Y</pubmed_authors><pubmed_authors>Jousma J</pubmed_authors><pubmed_authors>Du X</pubmed_authors><pubmed_authors>Han Z</pubmed_authors><pubmed_authors>Ong SB</pubmed_authors><pubmed_authors>Lee WH</pubmed_authors><pubmed_authors>Prosser BL</pubmed_authors><pubmed_authors>Yan G</pubmed_authors><pubmed_authors>Nukala SB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity.</name><description>&lt;h4>Background&lt;/h4>Mitochondrial dysfunction is a primary driver of cardiac contractile failure; yet, the cross talk between mitochondrial energetics and signaling regulation remains obscure. Ponatinib, a tyrosine kinase inhibitor used to treat chronic myeloid leukemia, is among the most cardiotoxic tyrosine kinase inhibitors and causes mitochondrial dysfunction. Whether ponatinib-induced mitochondrial dysfunction triggers the integrated stress response (ISR) to induce ponatinib-induced cardiotoxicity remains to be determined.&lt;h4>Methods&lt;/h4>Using human induced pluripotent stem cells-derived cardiomyocytes and a recently developed mouse model of ponatinib-induced cardiotoxicity, we performed proteomic analysis, molecular and biochemical assays to investigate the relationship between ponati</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-03T23:32:28.35Z</modification><creation>2025-04-03T23:32:28.35Z</creation></dates><accession>S-EPMC10940206</accession><cross_references><pubmed>38323474</pubmed><doi>10.1161/CIRCRESAHA.123.323683</doi><doi>10.1161/circresaha.123.323683</doi></cross_references></HashMap>